PBMWW
Psyence Biomedical Ltd. Warrant NASDAQ$0.03
Mkt Cap $1,896
52w Low $0.02
59.8% of range
52w High $0.03
50d MA $0.02
200d MA $0.02
P/E (TTM)
0.0x
EV/EBITDA
8.0x
P/B
0.0x
Debt/Equity
0.0x
ROE
—
P/FCF
-3.8x
RSI (14)
—
ATR (14)
—
Beta
0.31
50d MA
$0.02
200d MA
$0.02
Avg Volume
49.0K
About
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for t…
Data updated apr 28, 2026 5:33pm
· Source: massive.com